Welcome to our dedicated page for Terrascent SEC filings (Ticker: TSNDF), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
TerrAscend Corp. (TSNDF) files reports and disclosures with the U.S. Securities and Exchange Commission that provide additional detail on its North American cannabis operations, financing activities and material events. As a Canadian issuer whose common shares trade on the OTCQX Best Market, TerrAscend uses SEC filings such as Form 8-K to furnish press releases and describe significant transactions.
On this page, you can review TerrAscend’s Form 8-K filings that report material developments. For example, the company has filed an 8-K describing its quarterly financial results and business highlights for a specific period, incorporating a related press release by reference. Another 8-K details the Union Chill transaction, in which TerrAscend and certain consolidated entities entered into an option agreement with Union Chill Cannabis Company LLC, a dispensary operator in Hunterdon County, New Jersey. That filing explains the structure of the option to acquire a 35% equity interest, the issuance of convertible promissory notes, the total consideration and the conversion terms for the notes.
These filings also clarify that TerrAscend’s common shares trade on the OTCQX Best Market under the symbol TSNDF and identify the company as a Canadian issuer with a specific Commission File Number. The Union Chill 8-K further notes that the convertible notes and any common shares issuable upon conversion were offered and sold in reliance on an exemption from registration under Section 4(a)(2) of the U.S. Securities Act of 1933.
Stock Titan’s SEC filings page presents TerrAscend’s submissions as they are made available on EDGAR and pairs them with AI-powered summaries to help explain key terms, such as the nature of an 8-K, the implications of unregistered sales of equity securities, and how options, convertible notes and other instruments may affect the company’s capital structure. Investors can use this resource to quickly understand what TerrAscend is disclosing in its U.S. regulatory documents without having to parse every technical detail themselves.
TerrAscend Corp. reported that Chief People and Legal Officer Lynn K. Gefen received an award of 540,254 restricted share units (RSUs) on common shares, which will vest in equal annual installments over four years starting on April 3, 2026, subject to continued service. In a related move, 50,879 common shares were withheld by the company at $0.68 per share to cover tax obligations tied to RSU settlement. After these transactions, Gefen directly holds 1,094,718 common shares.
TerrAscend Corp. reported that President and CEO Ziad Ghanem received an award of 1,388,040 common-share RSUs, granted at $0.00 per share. These restricted share units vest in equal annual installments over four years starting on April 3, 2026, contingent on his continuous service.
In a related transaction on April 4, 105,051 common shares were withheld at $0.68 per share to cover tax obligations arising from RSU settlement under the company’s equity plan, rather than sold in the open market. After these transactions, Ghanem directly holds 2,896,899 common shares of TerrAscend.
TerrAscend Corp. President and CEO Ziad Ghanem reported a small tax-related share disposition. On the reported date, 3,027 Common Shares were withheld by the company at a price of $0.70 per share to cover his tax withholding obligations tied to restricted share unit settlement. After this withholding, he directly holds 1,613,910 Common Shares, indicating this was a routine compensation-related event rather than an open-market sale.
TerrAscend Corp. reported Q4 2025 net revenue of $66.1 million and full-year 2025 revenue of $260.6 million, slightly below 2024’s $268.1 million. Gross profit margin from continuing operations improved to 52.3% for 2025, up from 50.7%.
GAAP net loss from continuing operations was $24.5 million in 2025 versus $20.9 million in 2024, while Adjusted EBITDA from continuing operations was $67.8 million, compared with $70.2 million a year earlier. Adjusted EBITDA margin held broadly steady at 26.0%.
The company generated $33.9 million of net cash from continuing operations and $25.3 million of Free Cash Flow in 2025, marking its fourteenth consecutive quarter of positive operating cash flow. Cash and cash equivalents were $37.4 million at year-end.
TerrAscend refinanced $79 million of debt on a non-dilutive basis and added an uncommitted term loan facility of up to $35 million for strategic M&A. It advanced its strategic exit from Michigan, expanded in Ohio via the Ratio Cannabis acquisition, and renewed a share repurchase program of up to $10 million.
TerrAscend Corp. files its annual report describing a vertically integrated North American cannabis business and extensive regulatory risks. The company operates cultivation and processing facilities in Pennsylvania, New Jersey, Maryland and California, plus retail dispensaries in Ohio and Ontario under brands such as The Apothecarium, Kind Tree, Legend and Valhalla.
It highlights exposure to U.S. federal illegality of cannabis, potential IRS scrutiny under Section 280E, and uncertainty around possible rescheduling from Schedule I to Schedule III. As of June 30, 2025, non‑affiliate equity had an aggregate market value of $54,896,668, with 308,532,518 common shares outstanding as of March 11, 2026 and a workforce of 1,038 employees as of December 31, 2025.
TerrAscend Corp. disclosed that it has closed an option agreement to acquire a 35% equity interest in Union Chill Cannabis Company LLC, a single dispensary operator in Hunterdon County, New Jersey. As part of this Union Chill transaction, TerrAscend issued convertible promissory notes with an aggregate principal amount of $9,000,000 to the Union Chill sellers and agreed to pay an additional $4,000,000 in cash upon exercise of the option, for total consideration of $13,000,000.
The notes carry 6.5% annual interest, payable quarterly, and mature on December 26, 2029. Before maturity, each note may be converted in full into TerrAscend common shares at a conversion price of $1.89 per share, based on the outstanding principal plus accrued interest at the time of conversion. TerrAscend can prepay principal in minimum $50,000 increments with 30 days’ notice, while noteholders retain the right to convert during the notice period. The securities were issued as unregistered securities under Section 4(a)(2) of the Securities Act.
TerrAscend Corp. (TSNDF) director reports share sales and updated holdings. The reporting person sold 250,000 common shares on 11/21/2025 at a weighted-average price of $0.4146 per share and 296,174 common shares on 11/24/2025 at a weighted-average price of $0.4396 per share. After these transactions, the director beneficially owned 2,749,511 common shares following the first sale and 2,453,337 common shares following the second sale, held directly.
The filing explains that the shares sold were originally purchased in open market transactions between November 18, 2021 and March 21, 2022 at prices ranging from $5.53 to $6.30 per share and are being sold for tax reasons. It also notes that an aggregate of 1,041,021 shares were purchased on May 13, 2025 in multiple transactions at prices ranging from $0.37 to $0.43 per share, so the reporting person expects to hold approximately the same number of shares at a lower tax basis at the end of the current fiscal year compared to the prior year.
TerrAscend Corp. (TSNDF) shareholder plans sale under Rule 144. A Form 144 notice discloses an intent to sell 494,847 common shares through Morgan Stanley Smith Barney LLC, with an aggregate market value of $213,971.84. The filing notes that 305,483,308 common shares were outstanding, providing context for the size of the planned sale. The seller, Edward J. Schutter, reports prior open-market purchases of TerrAscend common stock between 2019 and 2021 and confirms a prior sale of 250,000 shares on 11/21/2025 for gross proceeds of $103,645. The signer represents that they are not aware of any undisclosed material adverse information about TerrAscend.
A holder of TSNDF common stock filed a Form 144 notice to potentially sell 546,174 common shares. The shares have an indicated aggregate market value of $213,007.86, based on the information provided. The issuer has 305,483,308 shares outstanding, giving context for the relative size of the planned sale. The shares were originally acquired on 11/18/2021 in an open-market, cash transaction and are expected to be sold around 11/19/2025 through broker Charles Schwab Corp on the OTC market.
TerrAscend Corp. furnished an 8-K to announce it issued a press release covering financial results and business highlights for the third quarter ended September 30, 2025. The press release is attached as Exhibit 99.1 and incorporated by reference. The company states the information under Item 2.02, including Exhibit 99.1, is being furnished and shall not be deemed “filed” under the Exchange Act. TerrAscend’s common shares trade on the OTCQX Best Market under the symbol TSNDF.